<DOC>
	<DOCNO>NCT00443482</DOCNO>
	<brief_summary>This study design demonstrate formoterol 12µg 24µg deliver new inhalation device ( Concept1 ) equivalent correspond dose formoterol deliver Aerolizer device term efficacy , patient persistent asthma .</brief_summary>
	<brief_title>Study Demonstrate Equivalence Formoterol 12 24 µg Delivered Via Two Types Single Dose Dry Powder Inhalers ( Concept1 Aerolizer )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>History asthma attack Forced expiratory volume 1 second ( measure well lungs work ) great 60 % predict value Asthma stable : patient admit hospital receive emergency room treatment Patients whose asthma drug need change within month prior start study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Asthma</keyword>
	<keyword>adult</keyword>
	<keyword>B2 agonist</keyword>
	<keyword>formoterol</keyword>
</DOC>